n-methyl-3,4-methylenedioxyamphetamine has been researched along with clozapine in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dudley, MW; Kehne, JH; Ketteler, HJ; McCloskey, TC; Schmidt, CJ; Sullivan, CK | 1 |
| Floriani, C; Masi, G; Mucci, M | 1 |
| Blessing, WW; Ootsuka, Y; Pedersen, NP; Seaman, B | 1 |
| Blessing, WW | 2 |
| Blessing, WW; Nalivaiko, E; Ootsuka, Y | 1 |
| Bomsien, S; Skopp, G | 1 |
| Abbas, AI; Beck, SG; Crawford, LK; Deneris, ES; Farrell, MS; Gingrich, J; Huang, XP; Irwin, JJ; Keiser, MJ; Kroeze, WK; Piel, DA; Roth, BL; Sciaky, N; Setola, V; Shoichet, BK; Yadav, PN | 1 |
| Baumann, MH; Kiyatkin, EA; Ren, S; Shaham, Y; Wakabayashi, KT | 1 |
| Kiyatkin, EA; Ren, SE | 1 |
10 other study(ies) available for n-methyl-3,4-methylenedioxyamphetamine and clozapine
| Article | Year |
|---|---|
Effects of the selective 5-HT2A receptor antagonist MDL 100,907 on MDMA-induced locomotor stimulation in rats.
Topics: 5,7-Dihydroxytryptamine; Animals; Brain Chemistry; Clozapine; Dopamine Antagonists; Fluorobenzenes; Male; Methiothepin; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Piperidines; Presynaptic Terminals; Rats; Receptors, Neurotransmitter; Ritanserin; Serotonin; Serotonin Agents; Serotonin Antagonists; Stimulation, Chemical | 1996 |
Acute catatonia after a single dose of ecstasy.
Topics: Acute Disease; Adolescent; Catatonia; Clozapine; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine | 2002 |
Clozapine reverses hyperthermia and sympathetically mediated cutaneous vasoconstriction induced by 3,4-methylenedioxymethamphetamine (ecstasy) in rabbits and rats.
Topics: Anesthesia; Animals; Antipsychotic Agents; Benzodiazepines; Body Temperature; Clozapine; Disease Models, Animal; Dose-Response Relationship, Drug; Ear; Fever; N-Methyl-3,4-methylenedioxyamphetamine; Olanzapine; Pirenzepine; Rabbits; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Skin; Sympathetic Nervous System; Tail; Treatment Outcome; Vasoconstriction; Wakefulness | 2003 |
New treatment for Ecstasy-related hyperthermia.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Clozapine; Disease Models, Animal; Fever; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Olanzapine; Serotonin Antagonists | 2003 |
Spinal 5-HT2A receptors regulate cutaneous sympathetic vasomotor outflow in rabbits and rats; relevance for cutaneous vasoconstriction elicited by MDMA (3,4-methylenedioxymethamphetamine, "Ecstasy") and its reversal by clozapine.
Topics: Animals; Clozapine; Ear, External; Fluorobenzenes; Injections, Intravenous; N-Methyl-3,4-methylenedioxyamphetamine; Phenols; Rabbits; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Serotonin Antagonists; Skin; Spine; Tail; Ultrasonography, Doppler, Pulsed; Vasoconstriction; Vasomotor System | 2004 |
Clozapine increases cutaneous blood flow and reduces sympathetic cutaneous vasomotor alerting responses (SCVARs) in rats: comparison with effects of haloperidol.
Topics: Animals; Antipsychotic Agents; Arousal; Clozapine; Dose-Response Relationship, Drug; Haloperidol; Injections, Subcutaneous; Laser-Doppler Flowmetry; Lipopolysaccharides; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Skin; Skin Temperature; Sympathetic Nervous System; Vasoconstriction; Vasomotor System | 2005 |
An in vitro approach to potential methadone metabolic-inhibition interactions.
Topics: Algorithms; Amitriptyline; Analgesics, Opioid; Atomoxetine Hydrochloride; Chromatography, Liquid; Citalopram; Clozapine; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Interactions; Isoenzymes; Kinetics; Methadone; Methylation; N-Methyl-3,4-methylenedioxyamphetamine; Oxidoreductases, N-Demethylating; Propylamines; Psychotropic Drugs; Pyridines; Pyrrolidines; Tandem Mass Spectrometry; Zolpidem | 2007 |
The presynaptic component of the serotonergic system is required for clozapine's efficacy.
Topics: Acoustic Stimulation; Action Potentials; Adrenergic Uptake Inhibitors; Amphetamines; Animals; Antipsychotic Agents; Behavior, Animal; Checkpoint Kinase 2; Clozapine; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Gene Expression Regulation; Ketanserin; Lysine; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase 3; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Patch-Clamp Techniques; Phencyclidine; Presynaptic Terminals; Protein Binding; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Radioligand Assay; Raphe Nuclei; Receptor, Serotonin, 5-HT1A; Reflex, Startle; Serotonin; Serotonin Antagonists; Stereotyped Behavior; Tritium; Tryptophan Hydroxylase | 2011 |
Clinically Relevant Pharmacological Strategies That Reverse MDMA-Induced Brain Hyperthermia Potentiated by Social Interaction.
Topics: Animals; Antipsychotic Agents; Body Temperature; Brain; Carbazoles; Carvedilol; Clozapine; Fever; Hallucinogens; Homeostasis; Labetalol; Male; N-Methyl-3,4-methylenedioxyamphetamine; Propanolamines; Rats, Long-Evans; Skin; Social Behavior; Sympathomimetics; Vasodilator Agents | 2016 |
MDMA, Methylone, and MDPV: Drug-Induced Brain Hyperthermia and Its Modulation by Activity State and Environment.
Topics: Animals; Antipsychotic Agents; Benzodioxoles; Body Temperature; Brain; Carbazoles; Carvedilol; Central Nervous System Stimulants; Clozapine; Environment; Fever; Humans; Interpersonal Relations; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Propanolamines; Pyrrolidines; Rats; Social Behavior; Synthetic Cathinone; Vasoconstriction; Vasodilator Agents | 2017 |